Nearly 30 drugmakers including Novartis and Bayer are moving to raise prices on their medicines next year, bucking pressure from President Donald Trump to halt increases. Allergan, GlaxoSmithKline, Amgen, and AstraZeneca are among the pharma companies planning to raise prices in January. (Reuters)

Altria has taken a 35% stake in e-cigarette company Juul for $12.8 billion, giving Altria the right to name one-third of Juul’s board members. Altria has also recently taken a 45% stake in Canadian cannabis company Cronos Group. (Bloomberg)

Americans are getting fatter, according to a government-backed report. The average weight of U.S. men was nearly 198 pounds in 2015-16, up from 189 pounds in 1999-2000. The average weight of U.S. women was up nearly seven pounds over the same period. (CNN)

Signups for healthcare coverage for 2019 through the Affordable Care Act were down 4% year-over-year, but the 8.5 million enrollments beat expectations with California and New York still left to report. Factors including uncertainty about the law’s future and a massive cut in the advertising budget for signups contributed to the decline. (Associated Press)

Merck KGaA is getting out of CAR-T development, selling its rights to Intrexon for $150 million in stock. German Merck has described the sale as a simplification of its research and development processes. German Merck had trailed competitors Novartis and Kite in the category. (Endpoints)